Insider

Verizon executive Kyle Malady sold company shares

Kyle Malady, executive vice president and group CEO of Verizon Business, sold 1,100 shares of Verizon Communications Inc. on the open market on October 13, 2026.

Verified against 2 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
a very tall building with a lot of windows
Photo by Willem Chan on Unsplash
1,100
Shares sold
$47,223
Total value
$42.93
Price per share

Key points

  • Kyle Malady sold 1,100 shares of Verizon Communications Inc. on October 13, 2026.
  • Selling shares under a 10b5-1 plan does not signal a change in executive sentiment or outlook on the company's future performance.

Transaction details

Kyle Malady sold 1,100 shares of Verizon Communications Inc. on October 13, 2026. The transaction totaled $47,223 at a weighted average price of $42.93 per share. The executive retained 101,066 shares after the transaction.

The transaction was executed under a Rule 10b5-1 trading plan, a preset selling schedule executives set up in advance, adopted on May 18, 2026, to avoid accusations of insider trading.

Share sale parameters

Total value
$47,223
Price per share
$42.93
Data from the original sources listed alongside.

What it means for investors

Selling shares under a 10b5-1 plan does not signal a change in executive sentiment or outlook on the company's future performance. Because the schedule was approved in advance, the transaction is a mechanical execution of commitments rather than a reaction to current market events.

Original sources

  1. 144 filing, October 13, 2026October 13, 2026SHA-256 of our archived copy 8dfab0c92386…
  2. 4 filing, October 14, 2026October 14, 2026SHA-256 of our archived copy a18374971786…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards